Showing 1 - 1 results of 1 for search 'Foxton, C', query time: 0.02s
Refine Results
-
1
A phase I dose escalation study of the tolerability of the oral VEGFR and EGFR inhibitor vandetanib in combination with the oral MEK1/2 inhibitor selumetinib in solid tumors by Pacey, S, Blackhall, F, Garcia-Corbacho, J, Lipplaa, A, Fusi, A, Kumar, S, Hategan, M, Derham, J, Laviste, G, Halford, S, Foxton, C, McLeod, R, Wan, S, Talbot, D
Published 2016Conference item